Cabergoline shortage

As of 4 Nov 2026, Cabergoline has a reported shortage in 4 of the 16 countries we track (Canada, Italy, Czechia, Norway), covering 6 products from 3 companies.

Is there a Cabergoline shortage?

Yes. As of 4 Nov 2026, Cabergoline is reported short in 4 of the 16 countries we track: Canada, Italy, Czechia, Norway. The earliest expected return is 23 Nov 2026 (Czechia). 4 of 6 affected products have no return date.

Countries4/16

Products6packs or presentations

Companies33 listed

Short since1 Jan 201511.8 years ago

Earliest return23 Nov 2026company estimate

Main reasonManufacturing problem

United StatesNo reported shortage Canada1 product short GermanyNo reported shortage FranceNo reported shortage Italy3 products short SpainNo reported shortage IrelandNo reported shortage AustriaNo reported shortage BelgiumNo reported shortage SwitzerlandNo reported shortage Czechia1 product short Norway1 product short SwedenNo reported shortage JapanNo reported shortage New ZealandNo reported shortage AustraliaNo reported shortage

How the shortage spread

All cross-border shortages

Countries in the order the shortage started there (earliest start date of a product still short). First reported in Canada on 1 Jan 2015; most recently in Czechia on 31 Aug 2026.

CACanadasince 1 Jan 2015
ITItalysince 14 Oct 2025
CZCzechiasince 31 Aug 2026

Not on the official list in: United States, Germany, France, Spain, Ireland, Austria, Belgium, Switzerland, Sweden, Japan, New Zealand, Australia.

Timeline

CanadaItalyCzechiaNorway

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Which companies are short

products short, all countries

Listed: Teva TEVA · NYSE / TASE, Aurobindo AUROPHARMA · NSE, Pfizer PFE · NYSE

Compared with similar medicines

ATC group G02CB · Prolactine Inhibitors

Affected products

Country	Product	Company	Since	Expected back	Reason
CA	ACT CABERGOLINE (8)	ACTAVIS PHARMA COMPANY	1 Jan 2015	not given	Manufacturing problem Requirements related to complying with good manufacturing practices
IT	CABERGOLINA AUROBINDO	AUROBINDO PHARMA (ITALIA) S.R.L.	14 Oct 2025	not given	Manufacturing problem Problemi produttivi
IT	DOSTINEX	PFIZER ITALIA S.R.L.	2 Feb 2026	not given	Manufacturing problem Problemi produttivi
IT	DOSTINEX discontinuation	PFIZER ITALIA S.R.L.	2 Feb 2026	not given	Manufacturing problem Problemi produttivi
CZ	DOSTINEX 0,5MG 0,5MG TBL NOB 2 II	Pfizer, spol. s r.o., Praha	31 Aug 2026	23 Nov 2026	Manufacturing problem Výrobní důvody
NO	Dostinex 0,5 mg tablett, 8 stk boks av plast anticipated	Pfizer AS	16 Nov 2026	17 Jan 2027	Increased demand Uventet økt etterspørsel

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Questions

Is there a Cabergoline shortage?

Yes. As of 4 Nov 2026, Cabergoline is reported short in 4 of the 16 countries we track: Canada, Italy, Czechia, Norway. The earliest expected return is 23 Nov 2026 (Czechia). 4 of 6 affected products have no return date.

When will Cabergoline be back in stock?

Companies expect supply back from 23 Nov 2026 in Czechia; Canada: no date given; Italy: no date given; Czechia: 23 Nov 2026; Norway: 17 Jan 2027. These are company estimates reported to each authority.

Why is Cabergoline in short supply?

The most common reason reported is: manufacturing problem. Reasons by product are listed in the table below.

Which companies have Cabergoline shortages?

Pfizer, Teva, Aurobindo.